These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
178 related articles for article (PubMed ID: 6292744)
1. Evidence of multiple receptor sites within the putative calcium channel. Ferry DR; Glossmann H Naunyn Schmiedebergs Arch Pharmacol; 1982 Oct; 321(1):80-3. PubMed ID: 6292744 [TBL] [Abstract][Full Text] [Related]
2. Molecular approach to the calcium channel. Glossmann H; Ferry DR; Goll A; Linn T Adv Myocardiol; 1985; 5():41-76. PubMed ID: 2578683 [TBL] [Abstract][Full Text] [Related]
3. Effects of Ca2+ channel blockers on Ca2+ translocation across synaptosomal membranes. Carvalho CA; Coutinho OP; Carvalho AP J Neurochem; 1986 Dec; 47(6):1774-84. PubMed ID: 2430061 [TBL] [Abstract][Full Text] [Related]
4. Identification of voltage operated calcium channels by binding studies: differentiation of subclasses of calcium antagonist drugs with 3H-nimodipine radioligand binding. Glossmann H; Ferry DR; Lübbecke F; Mewes R; Hofmann F J Recept Res; 1983; 3(1-2):177-90. PubMed ID: 6304295 [TBL] [Abstract][Full Text] [Related]
5. Chronotropic, inotropic, and vasodilator actions of diltiazem, nifedipine, and verapamil. A comparative study of physiological responses and membrane receptor activity. Millard RW; Grupp G; Grupp IL; DiSalvo J; DePover A; Schwartz A Circ Res; 1983 Feb; 52(2 Pt 2):I29-39. PubMed ID: 6831652 [TBL] [Abstract][Full Text] [Related]
6. Calcium channels: evidence for oligomeric nature by target size analysis. Ferry DR; Goll A; Glossmann H EMBO J; 1983; 2(10):1729-32. PubMed ID: 6315398 [TBL] [Abstract][Full Text] [Related]
7. Solubilization and partial purification of putative calcium channels labelled with [3H]-nimodipine. Glossmann H; Ferry DR Naunyn Schmiedebergs Arch Pharmacol; 1983 Aug; 323(4):279-91. PubMed ID: 6314149 [TBL] [Abstract][Full Text] [Related]
8. Mechanism of calcium channel inhibition by phenytoin: comparison with classical calcium channel antagonists. Messing RO; Carpenter CL; Greenberg DA J Pharmacol Exp Ther; 1985 Nov; 235(2):407-11. PubMed ID: 2414431 [TBL] [Abstract][Full Text] [Related]
9. Molecular pharmacology of the calcium channel: evidence for subtypes, multiple drug-receptor sites, channel subunits, and the development of a radioiodinated 1,4-dihydropyridine calcium channel label, [125I]iodipine. Glossmann H; Ferry DR; Goll A; Rombusch M J Cardiovasc Pharmacol; 1984; 6 Suppl 4():S608-21. PubMed ID: 6083403 [TBL] [Abstract][Full Text] [Related]
10. Differential labelling of putative skeletal muscle calcium channels by [3H]-nifedipine, [3H]-nitrendipine, [3H]-nimodipine and [3H]-PN 200 110. Ferry DR; Goll A; Glossmann H Naunyn Schmiedebergs Arch Pharmacol; 1983 Jul; 323(3):276-7. PubMed ID: 6312337 [TBL] [Abstract][Full Text] [Related]
11. Purified calcium channels have three allosterically coupled drug receptors. Striessnig J; Goll A; Moosburger K; Glossmann H FEBS Lett; 1986 Mar; 197(1-2):204-10. PubMed ID: 2419161 [TBL] [Abstract][Full Text] [Related]
13. Identification of putative calcium channels in skeletal muscle microsomes. Ferry DR; Glossmann H FEBS Lett; 1982 Nov; 148(2):331-7. PubMed ID: 6295810 [TBL] [Abstract][Full Text] [Related]
14. Calcium channel antagonist binding sites labeled by 3H-nimodipine in human brain. Peroutka SJ; Allen GS J Neurosurg; 1983 Dec; 59(6):933-7. PubMed ID: 6631515 [TBL] [Abstract][Full Text] [Related]
15. Functional interactions of calcium-antagonists in K+-depolarized smooth muscle. Spedding M Br J Pharmacol; 1983 Nov; 80(3):485-8. PubMed ID: 6640202 [TBL] [Abstract][Full Text] [Related]
16. Effects of a novel calcium channel agonist dihydropyridine analogue, Bay k 8644, on pig coronary artery: biphasic mechanical response and paradoxical potentiation of contraction by diltiazem and nimodipine. Dubé GP; Baik YH; Schwartz A J Cardiovasc Pharmacol; 1985; 7(2):377-89. PubMed ID: 2581094 [TBL] [Abstract][Full Text] [Related]
17. The interaction of the NK1 receptor antagonist CP-96,345 with L-type calcium channels and its functional consequences. Guard S; Boyle SJ; Tang KW; Watling KJ; McKnight AT; Woodruff GN Br J Pharmacol; 1993 Sep; 110(1):385-91. PubMed ID: 7693284 [TBL] [Abstract][Full Text] [Related]
18. (-)-3H-desmethoxyverapamil labelling of putative calcium channels in brain: autoradiographic distribution and allosteric coupling to 1,4-dihydropyridine and diltiazem binding sites. Ferry DR; Goll A; Gadow C; Glossmann H Naunyn Schmiedebergs Arch Pharmacol; 1984 Sep; 327(2):183-7. PubMed ID: 6092974 [TBL] [Abstract][Full Text] [Related]
19. Characterization of the binding sites for nimodipine and (-)-desmethoxyverapamil in bovine cardiac sarcolemma. Ruth P; Flockerzi V; von Nettelbladt E; Oeken J; Hofmann F Eur J Biochem; 1985 Jul; 150(2):313-22. PubMed ID: 2990931 [TBL] [Abstract][Full Text] [Related]
20. Relationship between the stereoselective negative inotropic effects of verapamil enantiomers and their binding to putative calcium channels in human heart. Ferry DR; Glossmann H; Kaumann AJ Br J Pharmacol; 1985 Apr; 84(4):811-24. PubMed ID: 2408698 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]